molecules testing eventually file new drug application fda order conduct clinical trials based experiences likelihood happening reasonably small pharma company smith kline french glaxosmithkline looking 1960s not work not strong analgesic solubility bad not drug delivery system state art pharmaceutical business thinking 1960s compound not sufficient brought market course country addicted people dying respiratory depression having drug effectively treat pain respiratory depression think pretty cool worth second look pharma companies decriminalize kratom blue face reality kratom indigenous thailand readily available drug users opting methamphetamines stronger kratom not mention dirt cheap widely available suspect thailand trying meth problem not effective not